Mexican radiationdermatitis management consensus.

Autor:	Tenorio C; Centro Medico ABC, Mexico City, Mexico., de la Mata D; Centro Medico ABC, Mexico City, Mexico., Leyva JAF; Hospital De Oncologia, IMSS, Mexico City, Mexico., Poitevin-Chacon A; Médica Sur, Mexico City, Mexico., Queijeiro MV; Centro Médico Nacional 20 de Noviembre, ISSSTE, Mexico City, Mexico., Gutiérrez GR; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Nogueda JC; Hospital De Oncologia, IMSS, Mexico City, Mexico., Cons LCD; Oncología San José Hermosillo, Sonora, Mexico., Hernandez YB; Hospital General de México, Mexico City, Mexico., Sánchez DR; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Cruz AAS; Centro Oncologico Estatal ISSEMYM, Mexico State, Mexico., Guardado GN; CMN 20 de Noviembre ISSSTE, Mexico City, Mexico., Tomasena MI; Centro Medico ABC, Mexico City, Mexico., Ortiz S; UMAE No 1, Hospital de Especialidades, CMN Bajio, IMSS, Guanajuato, Mexico., Del Bosque MAS; UMAE Hospital de Especialidades 25 Monterrey N.L., Nuevo Leon, Mexico., Garzón LAC; Secretaría de Marina (SEMAR), Mexico City, Mexico., Puch AES; Hospital de Especialidades Ignacio García Téllez, Yucatan, Mexico., Retif RP; Centro Universitario Contra el Cáncer, UMAE No 1, Hospital de Especialidades, CMN Bajio, IMSs, Guanajuato, Mexico., Arceo PRL; Centro Médico Nacional del Noreste UMAE 25 IMSS, Nuevo Leon, Mexico., López LHB; UMAE CMNO IMSS Especialidades, Jalisco, Mexico., Baldi CMT; Centro Medico ABC, Mexico City, Mexico.; Hospital De Oncologia, IMSS, Mexico City, Mexico.; Médica Sur, Mexico City, Mexico.; Centro Médico Nacional 20 de Noviembre, ISSSTE, Mexico City, Mexico.; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Oncología San José Hermosillo, Sonora, Mexico.; Hospital General de México, Mexico City, Mexico.; Centro Oncologico Estatal ISSEMYM, Mexico State, Mexico.; CMN 20 de Noviembre ISSSTE, Mexico City, Mexico.; UMAE No 1, Hospital de Especialidades, CMN Bajio, IMSS, Guanajuato, Mexico.; UMAE Hospital de Especialidades 25 Monterrey N.L., Nuevo Leon, Mexico.; Secretaría de Marina (SEMAR), Mexico City, Mexico.; Hospital de Especialidades Ignacio García Téllez, Yucatan, Mexico.; Centro Universitario Contra el Cáncer, UMAE No 1, Hospital de Especialidades, CMN Bajio, IMSs, Guanajuato, Mexico.; Centro Médico Nacional del Noreste UMAE 25 IMSS, Nuevo Leon, Mexico.; UMAE CMNO IMSS Especialidades, Jalisco, Mexico.
Jazyk:	angličtina
Zdroj:	Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2022 Oct 31; Vol. 27 (5), pp. 914-926. Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022).
DOI:	10.5603/RPOR.a2022.0101
Abstrakt:	Background: Radiotherapy (RT) is an essential element in cancer treatment: 50-70% of cancer patients receive RT at some time of the course of their disease. Of these, almost 95% experience some grade of radiation dermatitis (RD). RD can affect patient's quality of life during and after treatment. Consequently, the management of RD is important. There are few randomized controlled clinical trials on interventions used to prevent and treat RD and no standardized consensus on RD management. A panel of opinion leaders of the Mexican Society of Radiotherapy (SOMERA) took part in a study of oncologic practice in Mexico. The following clinical guide is referenced both by the national practice reality and international evidence. Materials and Methods: This RD management guide is based on input provided by 25 Mexican radiation oncologists, whose criteria were gathered using the Delphi Method and article review. Results: Twenty-one questions about experience in RD treatment were voted. More than 80% of the panel agreed with: the use of dermocosmetics/medical device in prevention and in treatment of RD grades 1-2. As for grade 3, they recommend individualizing each case and dermatologist evaluation. Topical steroids should be used when there is skin itching or pain. Consider the use of natural soaking elements. Skin care must be continued to avoid or reduce severity of late radiation skin lesions. Conclusion: This consensus was developed as a supportive educational tool that can be adapted to individual clinical needs, useful for professionals involved in the treatment of RT patients. (© 2022 Greater Poland Cancer Centre.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu